Molecular Analysis of Neuromuscular Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

In the Congenital Myopathy Research Program at Boston Children's Hospital and Harvard Medical School, the researchers are studying the congenital myopathies (neuromuscular diseases present from birth), including central core disease, centronuclear/myotubular myopathy, congenital fiber type disproportion, multiminicore disease, nemaline myopathy, rigid spine muscular dystrophy, SELENON (SEPN1), RYR1 myopathy, ADSS1 (ADSSL) Myopathy and undefined congenital myopathies. The primary goal of the research is to better understand the genes and proteins (gene products) involved in muscle functioning and disease. The researchers hope that our studies will allow for improved diagnosis and treatment of individuals with congenital myopathies in the future. For more information, visit the Laboratory Website at www.childrenshospital.org/research/beggs

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Individuals with a clinical or suspected diagnosis of a congenital myopathy and their family members

Locations
United States
Massachusetts
Genetics Division, Boston Children's Hospital
RECRUITING
Boston
Contact Information
Primary
Casie Genetti, M.S. C.G.C.
BeggsLabGC@childrens.harvard.edu
(617) 919-2169
Backup
Beggs lab
beggslab@enders.tch.harvard.edu
Time Frame
Start Date: 2003-08
Estimated Completion Date: 2050-01
Participants
Target number of participants: 4000
Sponsors
Collaborators: Muscular Dystrophy Association
Leads: Boston Children's Hospital

This content was sourced from clinicaltrials.gov